Related Experiment Video
Updated: May 26, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
[Smoking, obesity and diabetes: a clinically important interaction]
1Tobacco Research and Treatment Center, General Medicine Division, Harvard Medical School, Boston, MA 02114, USA. cclair@partners.org
Revue Medicale Suisse
|January 12, 2012
Summary
Quitting smoking offers significant health benefits, even if weight gain occurs. Pharmacologic support can aid smoking cessation and help manage weight, reducing risks for all smokers, including those with diabetes.
Area of Science:
- Public Health
- Metabolic Diseases
- Addiction Medicine
Context:
- Smoking, obesity, and diabetes are leading causes of premature death globally.
- Smokers often have lower body weight but higher abdominal fat compared to non-smokers.
- Smoking cessation is crucial for reducing mortality and morbidity.
Purpose:
- To highlight the complex relationship between smoking, weight management, and diabetes.
- To emphasize the benefits of smoking cessation despite potential weight gain.
- To advocate for pharmacologic interventions in smoking cessation programs.
Summary:
- Smoking cessation yields health benefits irrespective of weight gain.
- Smokers face increased risks of type 2 diabetes and its complications.
- Pharmacologic aids are recommended for all smokers to improve cessation rates and manage weight.
Impact:
- Informing public health strategies for smoking cessation.
- Guiding clinical practice for managing smokers, particularly those with diabetes.
- Reducing the global burden of premature death from smoking-related diseases.
More Related Videos
Related Concept Videos
01:26Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...